Table 2.
Answer options | Percentage (n) |
Corticosteroids | 96.2 (75) |
Infliximab 5 mg/kg | 92.3 (72) |
Aminosalicylates | 89.7 (70) |
Azathioprine1 | 76.9 (60) |
6-mercaptopurine1 | 70.5 (55) |
Methotrexate | 25.6 (20) |
Other | 14.1 (11) |
None | 1.3 (1) |
Reported use by physicians included either azathioprine or 6-mercaptopurine in different patients. 78 respondents.